Angiomyolipoma epidemiology and demographics: Difference between revisions
Category |
|||
| Line 3: | Line 3: | ||
{{CMG}}''' Associate Editor-In-Chief:''' {{CZ}}, {{Faizan}} | {{CMG}}''' Associate Editor-In-Chief:''' {{CZ}}, {{Faizan}} | ||
==Overview== | ==Overview== | ||
The [[incidence]] of angiomyolipoma is approximately 30 per 100,000 individuals worldwide. Females are more commonly affected with angiomyolipoma than males. Angiomyolipoma commonly affects individuals older than 40 years of age.<ref name=aaa>Raediopedia.org.http://radiopaedia.org/articles/renal-angiomyolipoma</ref> | The [[incidence]] of angiomyolipoma is approximately 30 per 100,000 individuals worldwide. Females are more commonly affected with angiomyolipoma than males. Angiomyolipoma commonly affects individuals older than 40 years of age.<ref name="aaa">Raediopedia.org.http://radiopaedia.org/articles/renal-angiomyolipoma</ref> | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
Angiomyolipoma occurs in more than | Angiomyolipoma occurs in more than 85% of cases with renal manifestations of [[tuberous sclerosis]].<ref name="pmid17003820">{{cite journal| author=Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA| title=Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors. | journal=Kidney Int | year= 2006 | volume= 70 | issue= 10 | pages= 1777-82 | pmid=17003820 | doi=10.1038/sj.ki.5001853 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17003820 }}</ref> | ||
===Incidence=== | ===Incidence=== | ||
The incidence of angiomyolipoma is approximately 30 per 100,000 individuals worldwide | The incidence of angiomyolipoma is approximately 30 per 100,000 individuals worldwide. | ||
===Gender=== | ===Gender=== | ||
Females are more commonly affected with angiomyolipoma than males. The female to male ratio is approximately 4 to 1.<ref name=aaa>Raediopedia.org.http://radiopaedia.org/articles/renal-angiomyolipoma</ref> | Females are more commonly affected with angiomyolipoma than males. The female to male ratio is approximately 4 to 1.<ref name="aaa">Raediopedia.org.http://radiopaedia.org/articles/renal-angiomyolipoma</ref> | ||
===Age=== | ===Age=== | ||
Angiomyolipoma commonly affects individuals older than 40 years of age.<ref name=aaa>Raediopedia.org.http://radiopaedia.org/articles/renal-angiomyolipoma</ref> | Angiomyolipoma commonly affects individuals older than 40 years of age.<ref name="aaa">Raediopedia.org.http://radiopaedia.org/articles/renal-angiomyolipoma</ref> | ||
==References== | ==References== | ||
Revision as of 04:31, 5 August 2018
|
Angiomyolipoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Angiomyolipoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Angiomyolipoma epidemiology and demographics |
|
Risk calculators and risk factors for Angiomyolipoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2], Faizan Sheraz, M.D. [3]
Overview
The incidence of angiomyolipoma is approximately 30 per 100,000 individuals worldwide. Females are more commonly affected with angiomyolipoma than males. Angiomyolipoma commonly affects individuals older than 40 years of age.[1]
Epidemiology and Demographics
Prevalence
Angiomyolipoma occurs in more than 85% of cases with renal manifestations of tuberous sclerosis.[2]
Incidence
The incidence of angiomyolipoma is approximately 30 per 100,000 individuals worldwide.
Gender
Females are more commonly affected with angiomyolipoma than males. The female to male ratio is approximately 4 to 1.[1]
Age
Angiomyolipoma commonly affects individuals older than 40 years of age.[1]
References
- ↑ 1.0 1.1 1.2 Raediopedia.org.http://radiopaedia.org/articles/renal-angiomyolipoma
- ↑ Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA (2006). "Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors". Kidney Int. 70 (10): 1777–82. doi:10.1038/sj.ki.5001853. PMID 17003820.